"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 3 | 4 |
| 1995 | 1 | 5 | 6 |
| 1996 | 1 | 10 | 11 |
| 1997 | 1 | 8 | 9 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 10 | 10 |
| 2000 | 1 | 12 | 13 |
| 2001 | 0 | 18 | 18 |
| 2002 | 1 | 20 | 21 |
| 2003 | 2 | 35 | 37 |
| 2004 | 4 | 37 | 41 |
| 2005 | 5 | 39 | 44 |
| 2006 | 5 | 59 | 64 |
| 2007 | 6 | 60 | 66 |
| 2008 | 8 | 84 | 92 |
| 2009 | 3 | 68 | 71 |
| 2010 | 9 | 75 | 84 |
| 2011 | 7 | 86 | 93 |
| 2012 | 9 | 85 | 94 |
| 2013 | 6 | 56 | 62 |
| 2014 | 8 | 69 | 77 |
| 2015 | 7 | 81 | 88 |
| 2016 | 11 | 88 | 99 |
| 2017 | 7 | 92 | 99 |
| 2018 | 21 | 87 | 108 |
| 2019 | 20 | 105 | 125 |
| 2020 | 9 | 106 | 115 |
| 2021 | 7 | 66 | 73 |
| 2022 | 1 | 26 | 27 |
| 2023 | 0 | 29 | 29 |
| 2024 | 2 | 49 | 51 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine. Blood. 2024 Nov 21; 144(21):2211-2222.
-
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood. 2024 Nov 21; 144(21):2169-2173.
-
Risk prediction for clonal cytopenia: multicenter real-world evidence. Blood. 2024 Nov 07; 144(19):2033-2044.
-
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy. Blood Adv. 2024 10 22; 8(20):5297-5305.
-
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays. Expert Rev Gastroenterol Hepatol. 2024 Oct; 18(10):587-596.
-
Risk for Suicide Attempts Assessed Using the Patient Health Questionnaire-9 Modified for Teens. JAMA Netw Open. 2024 Oct 01; 7(10):e2438144.
-
An Update on the Fracture Risk Assessment Tool: What Have We Learned over 15+ years? Endocrinol Metab Clin North Am. 2024 Dec; 53(4):531-545.
-
Germline CDH1 Variants and Lifetime Cancer Risk. JAMA. 2024 09 03; 332(9):722-729.
-
Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population. Diabetes Obes Metab. 2024 Nov; 26(11):5261-5271.
-
Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Stroke Vasc Neurol. 2024 Aug 27; 9(4):446-456.